Latin American Firms Seek Strategy Against USA

2 July 1997

ALIFAR, the Latin American pharmaceutical industry association thatrepresents the region's national companies, was to seek a common strategy against the "persistent threat of trade sanctions" from the USA in relation to the modernizing of intellectual property legislation, at its annual meeting, taking place last week in Quito, Ecuador, as the Marketletter went to press.

The association says that in the frontline are Argentina, Ecuador and Paraguay, countries which in April went to the top of the US blacklist of "patent pirates."

Host country Ecuador is currently being threatened with denial of preferential trade tariffs with the USA if by September it has not ratified a bilateral agreement on intellectual property. The deal was originally drawn up by former president Sixto Duran Ballen, but has since been thrown out by the current president, Abdala Bucaram, and by the present parliament.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight